AANS Neurosurgeon | Volume 26, Number 1, 2017


No Association Found Between Contrast Agents Used for MRIs and Nervous System Disorder

Bookmark and Share

In this study, researchers set out to find a connection between gadolinum exposure and parkinsonism. Gadolinum-based contrast agents are used during MRIs. In the past, safety concerns have emerged about the effects these contrast agents could potentially have on the brain. Previous studies have shown neurotoxic effects when these agents were used on animals. This study looked at 246,557 patients of which 99,739 of them underwent at least one MRI with contrast. To view the results of this study, click here.


Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland

12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans

2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.

Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany

Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.

Interactive Calendar

Comments are closed.